Against American Public Health Exceptionalism
Americans are no doubt conditioned to expect spectacular failure in the face of public health crises.

How should the FDA regulate recreational drugs, if it has the power to do so?
Key takeaways from a virtual panel discussion with three leading psychedelic policy advocates.
A mutual understanding of the term “microdosing psychedelics” is needed to conduct accurate research, promote regulations, and educate the wider population.
The Biden Administration has the opportunity to be the first administration to rid our legal system of cannabis regulation chaos.
Instead of fueling the long-failed War on Drugs by repressing kratom, the FDA should strengthen consumer confidence by creating uniform regulations.
Psychedelic drug reform is not occurring at the expense of other drug reforms. Instead, it paves the way for larger reforms.